Astrana Health annual ebitda margin
2010
2011
2012
2013
2015
2016
2016
2017
2017
2018
2019
2020
2021
2022
2023
2024
2025
Astrana Health EBITDA Margin Growth & History (ASTH)
Astrana Health's ebitda margin was 3.91% for fiscal 2025.
View full Astrana Health company overviewAstrana Health annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 3.91% | −1.86 pp |
| 2024 | 2024-12-31 | 5.76% | −1.62 pp |
| 2023 | 2023-12-31 | 7.38% | −3.26 pp |
| 2022 | 2022-12-31 | 10.65% | −4.30 pp |
| 2021 | 2021-12-31 | 14.95% | +0.56 pp |
| 2020 | 2020-12-31 | 14.39% | +5.34 pp |
| 2019 | 2019-12-31 | 9.04% | −11.68 pp |
| 2018 | 2018-12-31 | 20.72% | +5.51 pp |
| 2017 · Dec 31 | 2017-12-31 | 15.22% | +5.47 pp |
| 2017 · Mar 31 | 2017-03-31 | −17.22% | −1.53 pp |
| 2016 · Dec 31 | 2016-12-31 | 9.74% | — |
| 2016 · Mar 31 | 2016-03-31 | −15.70% | −14.61 pp |
| 2015 | 2015-03-31 | −1.09% | — |
| 2013 | 2014-01-31 | −36.99% | −10.53 pp |
| 2012 | 2013-01-31 | −26.46% | −18.62 pp |
| 2011 | 2012-01-31 | −7.84% | −8.23 pp |
| 2010 | 2011-01-31 | 0.39% | — |
Astrana Health quarterly ebitda margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q2.13
Q3.13
Q3.13
Q3.15
Q2.14
Q3.14
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q4.16
Q4.17
Q1.18
Q2.18
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 5.13% | +0.97 pp |
| Q1 2026 | 2026-03-31 | 4.56% | +0.14 pp |
| Q4 2025 | 2025-12-31 | 3.66% | +2.33 pp |
| Q3 2025 | 2025-09-30 | 3.64% | −3.81 pp |
| Q2 2025 | 2025-06-30 | 4.16% | −3.55 pp |
| Q1 2025 | 2025-03-31 | 4.42% | −4.29 pp |
| Q4 2024 | 2024-12-31 | 1.33% | +1.04 pp |
| Q3 2024 | 2024-09-30 | 7.46% | −5.01 pp |
| Q2 2024 | 2024-06-30 | 7.71% | −1.27 pp |
| Q1 2024 | 2024-03-31 | 8.71% | +0.81 pp |
| Q4 2023 | 2023-12-31 | 0.29% | −5.37 pp |
| Q3 2023 | 2023-09-30 | 12.46% | −4.84 pp |
| Q2 2023 | 2023-06-30 | 8.98% | +1.67 pp |
| Q1 2023 | 2023-03-31 | 7.91% | −3.71 pp |
| Q4 2022 | 2022-12-31 | 5.66% | +2.24 pp |
| Q3 2022 | 2022-09-30 | 17.30% | −8.16 pp |
| Q2 2022 | 2022-06-30 | 7.32% | −7.05 pp |
| Q1 2022 | 2022-03-31 | 11.62% | −3.14 pp |
| Q4 2021 | 2021-12-31 | 3.41% | −13.68 pp |
| Q3 2021 | 2021-09-30 | 25.46% | +2.13 pp |
| Q2 2021 | 2021-06-30 | 14.36% | +3.75 pp |
| Q1 2021 | 2021-03-31 | 14.76% | +9.26 pp |
| Q4 2020 | 2020-12-31 | 17.10% | +8.47 pp |
| Q3 2020 | 2020-09-30 | 23.33% | +13.73 pp |
| Q2 2020 | 2020-06-30 | 10.62% | −4.13 pp |
| Q1 2020 | 2020-03-31 | 5.49% | +4.33 pp |
| Q4 2019 | 2019-12-31 | 8.63% | +2.54 pp |
| Q3 2019 | 2019-09-30 | 9.60% | −27.24 pp |
| Q2 2019 | 2019-06-30 | 14.75% | +4.91 pp |
| Q1 2019 | 2019-03-31 | 1.16% | −21.24 pp |
| Q4 2018 | 2018-12-31 | 6.09% | +7.35 pp |
| Q3 2018 | 2018-09-30 | 36.84% | +10.05 pp |
| Q2 2018 · Jun 30 | 2018-06-30 | 9.84% | −1.06 pp |
| Q1 2018 · Mar 31 | 2018-03-31 | 22.40% | −1.64 pp |
| Q4 2017 | 2017-12-31 | −1.27% | +8.47 pp |
| Q2 2018 · Sep 30 | 2017-09-30 | 26.78% | +40.49 pp |
| Q1 2018 · Jun 30 | 2017-06-30 | 10.90% | +23.81 pp |
| Q4 2017 | 2017-03-31 | 24.04% | +55.06 pp |
| Q4 2016 | 2016-12-31 | −9.74% | +2.58 pp |
| Q2 2017 | 2016-09-30 | −13.70% | −10.76 pp |
| Q1 2017 | 2016-06-30 | −12.92% | +2.77 pp |
| Q4 2016 | 2016-03-31 | −31.02% | −32.06 pp |
| Q3 2016 | 2015-12-31 | −12.33% | +5.17 pp |
| Q2 2016 | 2015-09-30 | −2.95% | −20.54 pp |
| Q1 2016 | 2015-06-30 | −15.69% | +13.00 pp |
| Q4 2015 | 2015-03-31 | 1.05% | — |
| Q3 2015 · Dec 31 | 2014-12-31 | −17.50% | +10.81 pp |
| Q3 2014 | 2014-09-30 | 17.59% | +48.53 pp |
| Q2 2014 | 2014-06-30 | −28.69% | +38.82 pp |
| Q3 2015 · Dec 31 | 2013-12-31 | −28.31% | — |
| Q3 2013 · Oct 31 | 2013-10-31 | −30.97% | +41.90 pp |
| Q3 2013 · Sep 30 | 2013-09-30 | −30.94% | — |
| Q2 2013 · Jul 31 | 2013-07-31 | −52.22% | −48.70 pp |
| Q2 2013 · Jun 30 | 2013-06-30 | −67.51% | — |
| Q1 2013 | 2013-04-30 | −28.83% | −25.87 pp |
| Q4 2012 | 2013-01-31 | −20.51% | −3.30 pp |
| Q3 2012 | 2012-10-31 | −72.88% | −81.97 pp |
| Q2 2012 | 2012-07-31 | −3.52% | +3.86 pp |
| Q1 2012 | 2012-04-30 | −2.96% | +14.75 pp |
| Q4 2011 | 2012-01-31 | −17.21% | — |
| Q3 2011 | 2011-10-31 | 9.09% | +9.19 pp |
| Q2 2011 | 2011-07-31 | −7.38% | −5.89 pp |
| Q1 2011 | 2011-04-30 | −17.71% | — |
| Q3 2010 | 2010-10-31 | −0.10% | — |
| Q2 2010 | 2010-07-31 | −1.49% | — |
Astrana Health ebitda margin trends
Over the last five fiscal years, Astrana Health's ebitda margin decreased from 14.39% to 3.91%, a change of −10.48 percentage points. The latest reported quarter, Q2 2026, shows 5.13%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Astrana Health source filings ↗